Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
20 studies found for:    berberine
Show Display Options
Rank Status Study
1 Not yet recruiting Study of Berberine Hydrochloride in Prevention of Colorectal Adenomas Recurrence
Condition: Colorectal Adenoma
Intervention: Drug: Berberine hydrochloride
2 Recruiting The Therapeutic Effects of Statins and Berberine on the Hyperlipemia
Condition: Dyslipidemias
Interventions: Drug: Berberine;Atorvastatin or Rosuvastatin;   Drug: Atorvastatin or Rosuvastatin
3 Recruiting Helicobacter Pylori Eradication With Berberine Quadruple Therapy Versus Bismuth-containing Quadruple Therapy
Conditions: Gastritis;   Peptic Ulcer;   Dyspepsia
Interventions: Drug: Berberine;   Drug: Bismuth;   Drug: esomeprazole;   Drug: amoxicillin;   Drug: clarithromycin
4 Completed Role of Pioglitazone and Berberine in Treatment of Non-Alcoholic Fatty Liver Disease
Condition: Nonalcoholic Fatty Liver Disease
Interventions: Behavioral: Life style intervention;   Drug: pioglitazone;   Drug: berberine
5 Not yet recruiting Effects of Berberine Hydrochloride and Bifidobacterium in Prediabetes Prevention and Treatment
Condition: Prediabetes
Interventions: Drug: Bifidobacterium viable pharmaceutics;   Drug: Berberine Hydrochloride
6 Not yet recruiting Effects of Berberine Hydrochloride and Bifidobacterium in Diabetes Mellitus Prevention and Treatment
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Bifidobacterium viable pharmaceutics;   Drug: Berberine Hydrochloride
7 Recruiting Polycystic Ovary Syndrome (PCOS): Effect Of Letrozole and Berberine
Condition: Polycystic Ovary Syndrome
Interventions: Drug: Letrozole -Berberine;   Drug: Letrozole;   Drug: Berberine
8 Recruiting Effect of Berberine on Hormonal and Metabolic Features in Obese Women With Polycystic Ovary Syndrome (PCOS)
Conditions: Polycystic Ovary Syndrome;   Obesity
Interventions: Drug: Berberine;   Drug: Placebo
9 Completed Efficacy and Safety of Berberine in the Treatment of Diabetes With Dyslipidemia
Conditions: Diabetes Mellitus, Type 2;   Metabolic Syndrome
Intervention: Drug: Berberine
10 Completed Therapeutic Effects of Berberine in Patients With Type 2 Diabetes
Condition: Type 2 Diabetes
Interventions: Drug: Berberine;   Drug: Metformin
11 Completed The BANGALORE Study; Combination of Berberine, Lipoic Acid, and Picrorhiza
Condition: Metabolic Syndrome
Interventions: Dietary Supplement: CAR-191;   Other: Placebo
12 Completed Long Term Efficacy and Tolerability of a Nutraceutical Combination (Red Yeast Rice, Policosanols and Berberine) in Low-moderate Risk Hypercholesterolemic Patients: a Double-blind, Placebo Controlled Study
Condition: Hypercholesterolemia
Intervention: Other: nutraceutical combination (red yeast rice, policosanols and berberine)
13 Completed Armolipid Plus and Metabolic Syndrome
Condition: Metabolic Syndrome
Intervention: Dietary Supplement: Armolipid Plus
14 Recruiting The Role of a Combination of Nutraceuticals in the Control of Cardiovascular Risk
Condition: Metabolic Syndrome
Intervention: Drug: Armolipid Prev
15 Completed Combined Effects of Bioactive Compounds in Lipid Profile
Conditions: Hyperlipidemia;   Low-density-lipoprotein-type;   Elevated Triglycerides
Interventions: Dietary Supplement: Armolipid Plus;   Dietary Supplement: placebo
16 Recruiting Low-dose Statins and Nutraceuticals in High-intensity Statin-intolerant Patients
Condition: Coronary Artery Disease
Intervention: Drug: Association low-dose statin and nutraceuticals
17 Completed Effects of Armolipid Plus on Cholesterol Levels and Endothelial Function
Conditions: Hyperlipidemia;   Endothelial Dysfunction
Intervention: Dietary Supplement: Mixture of Berberine, Policosanol, Red Yeast, Placebo
18 Active, not recruiting Metabolic and Cardiovascular Effects of Armolipid Plus in Subjects With Metabolic Syndrome
Conditions: Metabolic Syndrome;   Insulin-resistance;   Left Ventricular Hypertrophy
Interventions: Dietary Supplement: Armolipid Plus;   Dietary Supplement: Placebo
19 Recruiting Ezetimibe Versus Nutraceuticals in Statin-intolerant Patients
Condition: Coronary Artery Disease
Interventions: Drug: Ezetimibe;   Drug: Nutraceuticals
20 Not yet recruiting Nutraceuticals to Improve Lipid Profile in European Countries
Condition: Hyperlipidemia
Interventions: Behavioral: Non-pharmacologic intervention;   Drug: Nutraceuticals (Armolipid Plus)

Indicates status has not been verified in more than two years